Doxorubicin

Regimen

Hepatocellular Cancer Adult, Primary

• Doxorubicin (Adriamycin) 60-75 mg/m2 iv
• Q3w

References

Gish RG et al. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol 2007; 25:3069

Lai, CL et al. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 1988; 62:479

Sarcoma

• Doxorubicin (Adriamycin) 75 mg/m2 iv bolus q3w

References

Santoro, A et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995; 13:1537